HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency.

Abstract
Rhizomelic chondrodysplasia punctata (RCDP) is a group of disorders with overlapping clinical features including rhizomelia, chondrodysplasia punctata, coronal clefts, cervical dysplasia, congenital cataracts, profound postnatal growth retardation, severe intellectual disability, and seizures. Mutations in PEX7, GNPAT, and AGPS, all involved in the plasmalogen-biosynthesis pathway, have been described in individuals with RCDP. Here, we report the identification of mutations in another gene in plasmalogen biosynthesis, fatty acyl-CoA reductase 1 (FAR1), in two families affected by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity. Exome analyses revealed a homozygous in-frame indel mutation (c.495_507delinsT [p.Glu165_Pro169delinsAsp]) in two siblings from a consanguineous family and compound-heterozygous mutations (c.[787C>T];[1094A>G], p.[Arg263(∗)];[Asp365Gly]) in a third unrelated individual. FAR1 reduces fatty acids to their respective fatty alcohols for the plasmalogen-biosynthesis pathway. To assess the pathogenicity of the identified mutations, we transfected human embryonic kidney 293 cells with plasmids encoding FAR1 with either wild-type or mutated constructs and extracted the lipids from the cells. We screened the lipids with gas chromatography and mass spectrometry and found that all three mutations abolished the reductase activity of FAR1, given that no fatty alcohols could be detected. We also observed reduced plasmalogens in red blood cells in one individual to a range similar to that seen in individuals with RCDP, further supporting abolished FAR1 activity. We thus expand the spectrum of clinical features associated with defects in plasmalogen biosynthesis to include FAR1 deficiency as a cause of syndromic severe intellectual disability with cataracts, epilepsy, and growth retardation but without rhizomelia.
AuthorsRebecca Buchert, Hasan Tawamie, Christopher Smith, Steffen Uebe, A Micheil Innes, Bassam Al Hallak, Arif B Ekici, Heinrich Sticht, Bernd Schwarze, Ryan E Lamont, Jillian S Parboosingh, Francois P Bernier, Rami Abou Jamra
JournalAmerican journal of human genetics (Am J Hum Genet) Vol. 95 Issue 5 Pg. 602-10 (Nov 06 2014) ISSN: 1537-6605 [Electronic] United States
PMID25439727 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Lipids
  • Aldehyde Oxidoreductases
  • hexadecanal dehydrogenase (acylating)
Topics
  • Abnormalities, Multiple (genetics)
  • Aldehyde Oxidoreductases (chemistry, deficiency, genetics)
  • Base Sequence
  • Cataract (genetics)
  • Chromatography, Gas
  • Deficiency Diseases (genetics, pathology)
  • Epilepsy (genetics)
  • Female
  • Genotype
  • HEK293 Cells
  • Humans
  • INDEL Mutation (genetics)
  • Intellectual Disability (genetics)
  • Lipids (analysis)
  • Magnetic Resonance Imaging
  • Male
  • Mass Spectrometry
  • Models, Molecular
  • Molecular Sequence Data
  • Pedigree
  • Sequence Analysis, DNA
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: